Horses are usually infected during the first months of life by several equine herpesviruses, such as EHV-1, EHV-4 or EHV-2. The persistence of these respiratory viruses through establishment of latency, often characterised by an absence of clinical signs, represents a real risk to the horse population. Reactivation of latent EHV could cause disease in both carriers and naive animals in contact. A better understanding of the immune response to EHV infection is necessary to improve our methods of prevention and decrease the risk of transmission. The objectives of this study were 1/ to characterise the cytokine gene expression profile of PBMC after in vitro EHV infection (EHV-1, EHV-4 and EHV-2) and 2/ To determine the efficacy of the inactivated Parapoxvirus ovis (iPPVO), a known immunomodulator in horses , against these same viruses. PBMC were isolated from 3 horses and infected in vitro with EHV-1, EHV-4 or EHV-2, in the presence or absence of iPPVO. In vitro culture of PBMC with EHV-1, EHV-4, EHV-2 and iPPVO induced a significant increase of IFN-a, IFN-b and IFN-g gene expression. Moreover, EHV-2 induced a significant increase of IL-1b, IL-6 and TNF-a mRNA. The presence of iPPVO induced an earlier and stronger expression of IFN-a, IFN-b and IFN-g during EHV infection. The presence of iPPVO reduced also the inflammatory response induced by EHV-2. In conclusion, this study suggests that the presence of iPPVO potentiates the development of the immune response during infection EHV in vitro. In virology, different conventional methods are commonly used for virus titration and infectivity studies. Most of them are based on direct examination of viral cytopathic effect, which is time consuming, tedious and requires an endpoint reading. The RTCA xCELLigence system (ACEA Biosciences) has been developed to follow cellular events and their dynamics in real time using a micro-electrical biosensor technology. The aim of this study was to evaluate the feasibility of using this biosensor technology to measure the effect of different equid herpesviruses on equine dermal cell cultures, with or without antiviral acyclovir treatment. Cells were infected with EHV-1 (VR700), EHV-4 (VR2230), EHV-2 (VR701) or EHV-3 (VR352). The viral effects were monitored by 3 different methods: impedance measurements (RTCA), cytopathic effects recording (microscopy) and viral load quantification (qPCR). The RTCA technology showed a dose dependent drop of the cellular index induced by specific impedance variations measured during growth of each virus tested. These results correlated with the cytopathic effect induced by the different herpesvirus species, as well as viral loads measured by qPCR. For example, after 3 days of incubation with EHV-1, RTCA results showed an increase of the cellular index from 0% (infection without antiviral) to 45% and 100% in presence of Acyclovir (10ml/ mL and 100 mg/mL, respectively). These results are correlated with the decreased of viral load measured in the presence of Acyclovir: 10 10 genome copies/mL with EHV-1 only, 10 6 copies/mL with EHV-1 + Acyclovir 10 mg/ mL and 10 5 copies/mL with EHV-1 + Acyclovir 100 mg/ mL. In conclusion, the cellular impedance monitoring system is a new real-time method to monitor cell growth and viral proliferation in cell cultures. This technology is well adapted for high-throughput screening of antiviral molecules. In fact, the xCELLigence system enables continuous impedance measurement and quantification of cell adhesion, proliferation, cell death and detachment during viral infection. ¥ shared first authorship Equine gamma herpesvirus type 5 (EHV-5) is related to the human Epstein eBarr virus (EBV) and has frequently been observed in equine populations worldwide. EHV-5 was previously assumed to be low to nonpathogenic, however, studies have also related the virus to the severe lung disease equine multinodular pulmonary fibrosis (EMPF). Genetic information of EHV-5 is scanty, where the whole genome was recently described and only limited nucleotide sequences are available. In this study, partial of the EHV-5 glycoprotein B (gB) gene were analyzed in nine horses by using next generation sequencing (NGS). The included samples were from eight healthy Standardbred trotters at the same professional training yard that were sampled twice with one year apart, and from one horse diagnosed with EMPF from which samples were taken pre and post mortem. The analysis resulted in obtaining of 27 partial gB gene sequences, 11 unique sequence types and 5 amino acid sequences. These sequences could be classified within four genotypes (I-IV) of EHV-5 gB gene based on the degree of similarity of the nucleotide and amino acid sequences, and in this work horses were shown to be identified with up to three different genotypes at the same time. The observations showed a range of interactions between EHV-5 and the host over time, where the same virus persists in some horses whereas others have a more dynamic infection pattern including strains from different genotypes. This study provides insight into genetic variation and dynamic of EHV-5 and highlights that further work is needed to understand the EHV-5 interaction with its host. Infections caused by equine Gammaherpesvirus 2 and 5 usually occur during the early stages of the life of horses, followed by periodic reactivation of a latent infection. The occurrence of equine herpesvirus 2 (EHV-2) is related with immunosuppression and has been associated with outbreaks of respiratory disease. Alternatively, equine herpesvirus 5 (EHV-5) has tropism for the respiratory tract and has been related to equine multinodular pulmonary fibrosis. Since the presence of these viruses was never reported in Brazil, the aim of this study was to detect EHV-2 and -5 in Brazilian horses. Twenty-six nasal swabs were collected from horses without signs of respiratory distress from two distinct pure-breed farms (A, n¼18; B, n¼8). Nucleic acid purification was performed by using a combination of the phenol/chloroform/isoamyl alcohol and silica/guanidinium isothiocyanate methods. The identification of EHV-2 and -5 was done by using a nested PCR assay that targeted the gB gene. The PCR results were confirmed by sequencing using ABI 3500 Genetic Analyzer. From Farm A, 5 nasal swabs were positive for EHV-2, 10 contained EHV-5 DNA, and one sample had the DNA of both viruses. From the second farm, 7 samples were positive for EHV-2, 6 for EHV-5, and 6 contained the DNA of both viruses. In summary, from a total of 26 nasal swabs, 46.1% (12) were contained EHV-2 DNA, 61.5% (16) were positive for EHV-5, and 26.9% (7) had the DNA of both viruses. This was the first detection of equine gammaherpesviruses 2 and 5 in horses from Brazil. These results obtained from asymptomatic horses suggest that these viruses are probably endemic in Brazil, similarly as previously reported in Europe, USA and Australia.
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